Is BPC-157 legal in the US?
No. It is not approved and is sold as a research chemical.
BPC-157 is not approved by the FDA for any use and is sold as a research chemical. The FDA put it in Category 2 of substances nominated for compounding in 2023 over safety concerns; the nominators later withdrew it, and the agency's Category 2 page now lists it as nominated but withdrawn. In July 2026 the Pharmacy Compounding Advisory Committee voted 8 to 6 to recommend adding it to the 503A bulks list, but the FDA has not proposed a rule to do so, so it still cannot be lawfully compounded.
No. It is not approved for any use. In 2023 the FDA put it in Category 2 for compounding. The nominators later withdrew it, and the Category 2 page now lists it as nominated but withdrawn. An advisory committee voted 8 to 6 in July 2026 to recommend adding it to the compounding list. The FDA has not proposed a rule to do so, so pharmacies still cannot lawfully compound it. 678
A prescription cannot be filled lawfully. No approved product exists, and compounding is not allowed because the FDA has not added it to the 503A bulks list. Clinics that supply it are operating outside FDA rules. 78
More on BPC-157
Citations
- International Journal of Molecular Sciences 2026: BPC 157 pentadecapeptide review doi.org
- Pharmaceuticals 2025: BPC 157 as a cytoprotective agent doi.org
- STAT News 2026: BPC-157 researcher Predrag Sikiric addresses skeptics statnews.com
- HSS Journal 2025: emerging use of BPC-157 in orthopaedic sports medicine, systematic review (DOI) doi.org
- ClinicalTrials.gov: NCT02637284 clinicaltrials.gov
- FDA: bulk drug substances used in compounding under section 503A fda.gov
- FDA: bulk drug substances that may present significant safety risks in compounding fda.gov
- STAT News 2026: FDA peptide compounding panel votes statnews.com
- USADA: BPC-157, a prohibited peptide usada.org
- Cell and Tissue Research 2019: BPC 157 cytoprotection review doi.org
- Staresinic 2003, J Orthop Res: BPC 157 accelerates healing of transected rat Achilles tendon pubmed.ncbi.nlm.nih.gov
- ClinicalTrials.gov registry clinicaltrials.gov
- HSS Journal 2025: emerging use of BPC-157 in orthopaedic sports medicine, systematic review pubmed.ncbi.nlm.nih.gov
- WADA: Prohibited List wada-ama.org
Reference information only, not medical advice. Drawn from the BPC-157 article, fact-checked against the cited sources. No dosing anywhere on this site.